Detection of β-Lactamase-Producing Enterococcus faecalis and Vancomycin-Resistant Enterococcus faecium Isolates in Human Invasive Infections in the Public Hospital of Tandil, Argentina
- PMID: 32093230
- PMCID: PMC7168638
- DOI: 10.3390/pathogens9020142
Detection of β-Lactamase-Producing Enterococcus faecalis and Vancomycin-Resistant Enterococcus faecium Isolates in Human Invasive Infections in the Public Hospital of Tandil, Argentina
Abstract
The study's aim was to analyze the population structure of enterococci causing human invasive infections in a medium-sized Argentinian Hospital coincidental with a 5 year-period of increased recovery of antibiotic resistant enterococci (2010-2014). Species identification (biochemical testing/MALDI-TOF-MS), antimicrobial susceptibility (disk-diffusion) and clonal relatedness (PFGE/MLST/BAPS) were determined according to standard guidelines. β-lactamase production was determined by a nitrocefin test and confirmed by PCR/sequencing. The isolates were identified as Enterococcus faecalis and Enterococcus faecium at a 2:1 ratio. Most of the E. faecalis isolates, grouped in 25 PFGE-types (ST9/ST179/ST236/ST281/ST388/ST604/ST720), were resistant to high-levels (HLR) of gentamicin/streptomycin. A ST9 clone (bla+/HLR-gentamicin) was detected in patients of different wards during 2014. E. faecium isolates were grouped in 10 PFGE-types (ST25/ST18/ST19/ST52/ST792), with a low rate of ampicillin resistance. Five vancomycin-resistant E. faecium, three vanA (ST792/ST25) and two vanB (ST25) were detected. The ST25 clone carried either vanA or vanB. The recovery of a bla+-ST9-E. faecalis clone similar to that described in the late 1980s in Argentina suggests the possibility of a local hidden reservoir. These results reflect the relevance of local epidemiology in understanding the population structure of enterococci as well as the emergence and spread of antimicrobial resistance in predominant enterococcal clonal lineages.
Keywords: Enterococcus faecalis; Enterococcus faecium; VRE; antibiotic resistance; bla+; invasive infections.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Werner G., Coque T.M., Hammerum A.M., Hope R., Hryniewicz W., Johnson A., Klare I., Kristinsson K.G., Leclercq R., Lester C.H., et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13:19046. - PubMed
-
- Togneri A., Corso A., González J., Lopardo H., Podestá L., Gagetti P., Peréz M., Rodríguez V., Rodríguez M., Ríos L., et al. Análisis clínico-epidemiológico de la portación intestinal de enterococos resistentes a vancomicina en una unidad de terapia intensiva. Rev. Argent. Microbiol. 2005;37:26–33. - PubMed
-
- Lopardo H., Blanco A., Carbonaro M., Ruvinsky S., Andión E., Venuta E., Corso A., Gagetti P., Bologna R. Impacto de 10 años de vigilancia de colonización con enterococos resistentes a vancomicina (ERV) en un hospital pediátrico de alta complejidad. Med. Infant. 2008;1:114–120.
Grants and funding
- PI15/1581/Instituto de Salud Carlos III
- PI15/1581/European Regional Development Fund
- CB06/02/0053/European Regional Development Fund
- PPID/M007-UNLP 2016/Secretaría de Políticas Universitarias, Ministerio de Educación y Deportes, República Argentina
- CB06/02/0053/Centros de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBER-ESP)
LinkOut - more resources
Full Text Sources
